Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Net income (loss)	$ (3,156,485)	$ 334,355
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	46,133	35,676
Net (gains) losses realized on the sale of securities	108,643	(229,992)
Unrealized (gains) losses on equity securities	1,638,847	(20,814)
Change in fair value of embedded derivative	177,596	108,526
(Accretion) amortization of investment securities, net	(55,431)	182,183
Deferred acquisition costs capitalized	(479,681)	(453,040)
Deferred acquisition costs amortized	1,205,554	1,210,345
Value of business acquired amortized	92,420	92,420
Interest credited on deposit type contracts	1,597,392	1,606,340
(Increase) decrease in operating assets:
Change in funds withheld	(656,085)	(2,492,319)
Investment income due and accrued	(176,441)	(275,468)
Reinsurance related assets	720,784	(27,284)
Deferred tax assets, net of valuation allowance	(53,817)	(1,208,417)
Other assets	328,735	1,060,110
Increase (decrease) in operating liabilities:
Policyowner benefit reserves	4,207,406	4,046,010
Dividend Accumulation	3,425	2,135
Advance premiums	32,553	34,051
Other liabilities	(144,776)	171,602
Accounts payable and accrued expenses	(648,869)	(764,546)
Net cash provided by operating activities	4,787,903	3,411,873
Cash Flows from investing activities:
Purchase of equity investments	(1,415,492)	(1,252,485)
Purchase of mortgage investments	(8,295,919)	(2,591,328)
Purchase of other invested assets	(156,009)	0
Proceeds from equity sales	1,167,810	675,534
Proceeds from mortgage repayments	3,748,177	2,104,322
Transfers from (to) funds withheld	967,462	200,000
Interest on policy loans	683	0
Increase (decrease) in policy loans	137,678	(9,616)
Purchase of property, equipment and software	(56,401)	(78,037)
Net cash used in investing activities	(9,804,712)	(1,713,117)
Cash Flows from financing activities:
Receipts on deposit-type contracts	5,389,262	3,987,535
Withdrawals on deposit-type contracts	(3,243,267)	(1,937,457)
Repayment of FHLB advance	(1,000,000)	0
Proceeds received from issuance of common stock, net of costs of issuance	6,973	(114,245)
Net cash provided by financing activities	1,152,968	1,935,833
Net increase (decrease) in cash and cash equivalents	(3,863,841)	3,634,589
Cash and Cash Equivalents:
Beginning	7,955,348	4,320,759
Ending	4,091,507	7,955,348
Supplemental Disclosure of Non-Cash Information
Funds withheld assumed deposits on deposit-type contracts	639,610	1,371,325
Funds withheld assumed withdrawals on deposit-type contracts	(915,520)	(1,542,077)
Commissions and expense allowances deducted from funds withheld	(908,074)	(942,548)
Assets transferred on settlement of funds withheld	45,800,032	0
Investment income due and accrued transferred on settlement of funds withheld	1,211,420	0
Reinsurance related assets transferred on settlement of funds withheld	1,049,088	0
Investment expenses payable transferred on settlement of funds withheld	(408,609)	0
Fixed Income Investments [Member]
Cash Flows from investing activities:
Purchase of fixed income investments	(10,865,054)	(2,751,482)
Proceeds from fixed income sales and repayments	$ 4,962,353	$ 1,989,975